Adverse effects of stimulant drugs in a community sample of drug users

https://doi.org/10.1016/S0376-8716(96)01324-5Get rights and content

Abstract

A sample of drug users (n = 158) were contacted and interviewed in non-clinical community settings about their use of Ecstasy, cocaine powder, and amphetamines and the adverse effects of these drugs. Subjects reported a wide range of adverse effects including anxiety problems, depression, mood swings, feelings of paranoia, and panic attacks. Sleep and appetite disturbances were the most commonly reported problems. About half of all subjects reported depression and paranoid feelings associated with their stimulant use. Many of those reporting problems stated that these were mild. However, for all drugs, a substantial minority of users reported adverse effects which they rated as ‘severe’. Between 30 and 55% of the sample reported having had at least one ‘severe’ adverse effect (30% cocaine, 35% Ecstasy and 55% amphetamine). There were clear differences between the different drugs in the likelihood and reported severity of adverse effects. Amphetamine use was associated with significantly more adverse effects and with more severe adverse effects than Ecstasy or cocaine. Cocaine powder was associated with the least severe adverse effects. A common pattern of drug use involved the use of depressant drugs such as opiates and benzodiazepines in addition to stimulants. The stimulant and depressant users were more likely than the stimulants-only users to use stimulants by injection and more likely to report adverse effects associated with stimulant use. The stimulant and depressant users were also more likely to have been treated for a drug problem. Approximately a quarter of the sample stated that they had stopped using stimulants up to the point of interview as a result of their bad experiences.

References (26)

  • M. Gossop et al.

    Amphetamine withdrawal and sleep disturbance

    Drug Alcohol Depend.

    (1982)
  • K. Anderson

    The use and misuse of Ecstasy (MDMA) in Scotland: A pilot study

    (1994)
  • J. Colliver

    A decade of DAWN: cocaine related cases 1976–1985

    (1987)
  • S. Darke et al.

    The use of benzodiazepines among regular amphetamine users

    Addiction

    (1994)
  • G.P. Dowling

    Human deaths and toxic reactions attributed to 3,4-methylenedioxymethamphetamine and MDEA

  • J. Downing

    The psychological and physiological effects of MDMA on normal volunteers

    J. Psychoact. Drugs

    (1986)
  • M. Gossop et al.

    The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users

    Addiction

    (1995)
  • M. Gossop et al.

    Severity of heroin dependence and HIV risk. I. Sexual Behaviour

    Aidscare

    (1993)
  • M. Gossop et al.

    Severity of heroin dependence and HIV risk. II. Sharing Injecting Equipment

    Aidscare

    (1993)
  • M. Gossop et al.

    Cocaine patterns of use, routes of administration and SDS

    Br. J. Psychiatry

    (1994)
  • W.R. Gove et al.

    Drug use and mental health among a representative national sample of young adults

    Social Forces

    (1979)
  • S.T. Green et al.

    Increasing ecstasy use among Glasgow-drug injectors

    Addiction Res.

    (1995)
  • P. Griffiths et al.

    Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues

    Addiction

    (1993)
  • Cited by (166)

    • Cocaine Use in Adolescents and Young Adults

      2019, Pediatric Clinics of North America
    View all citing articles on Scopus
    View full text